Delay of treatment initiation is the single most important modifiable risk factor for developing refractory rheumatoid arthritis.
Our data identified delay to initial treatment, female gender and higher disease activity as important predictors of a later refractory course of RA. Delay of treatment initiation is the single most important modifiable risk factor of refractory disease.
Bécède et al. (Sun,) studied this question.